Investing is Hard: Pfizer
Imagine if 5 years ago we had a crystal ball. And we looked into that crystal ball and we told you:
- There is going to be a pandemic
- Pfizer is going to sell more than $70 billion of a vaccine in response to that pandemic
…….You would almost certainly think “Pfizer stock is going to soar on that news”.
Nope.
Over the last 5 years, Pfizer stock has trailed the S&P 500 Index by a whopping 67%.
- Pfizer stock price Sept 18, 2018: $40.23
- Pfizer stock price Sept 18, 2023: $33.64
Investing based on news, even when you already know the news, is hard.
Authors: Keith Wagner, Connor Wagner
Source: FactSet, Inc.
The views expressed herein are those of the author and do not necessarily reflect the views of Raymond James & Associates or its affiliates. All opinions are subject to change without notice. Neither the information provided nor any opinion expressed constitutes a solicitation for the purchase or sale of any security. Past performance is no guarantee of future results.
The investments listed may not be suitable for all investors. Raymond James & Associates recommends that investors independently evaluate particular investments, and encourages investors to seek the advice of a financial advisor. The appropriateness of a particular investment will depend upon an investor's individual circumstances and objectives.
The information has been obtained from sources considered to be reliable, but we do not guarantee that the foregoing material is accurate or complete. Investing involves risk and you may incur a profit or loss regardless of strategy selected, including diversification and asset allocation. Keep in mind that individuals cannot invest directly in any index, and index performance does not include transaction costs or other fees, which will affect actual investment performance. Future investment performance cannot be guaranteed, investment yields will fluctuate with market conditions.
